Moderna (NASDAQ: MRNA), pharmaceutical giant, is on its second stage of coronavirus vaccine. mRNA shares – to date – have risen nearly 160%. The company is one of a handful of biotechnologists working on a …
from
https://alphabetastock.com/2020/05/08/moderna-mrna-rockets-after-fda-news/
No comments:
Post a Comment